Endoplasmic reticulum stress-induced hepatocellular death pathways mediate liver injury and fibrosis via Stimulator of Interferon Genes. by Iracheta-Vellve, Arvin et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
GSBS Student Publications Graduate School of Biomedical Sciences 
2016-11-03 
Endoplasmic reticulum stress-induced hepatocellular death 
pathways mediate liver injury and fibrosis via Stimulator of 
Interferon Genes. 
Arvin Iracheta-Vellve 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/gsbs_sp 
 Part of the Biochemistry Commons, Immunity Commons, and the Molecular Biology Commons 
Repository Citation 
Iracheta-Vellve A, Petrasek J, Gyongyosi B, Satishchandran A, Lowe P, Kodys K, Catalano D, Calenda CD, 
Kurt-Jones EA, Fitzgerald KA, Szabo G. (2016). Endoplasmic reticulum stress-induced hepatocellular 
death pathways mediate liver injury and fibrosis via Stimulator of Interferon Genes.. GSBS Student 
Publications. https://doi.org/10.1074/jbc.M116.736991. Retrieved from 
https://escholarship.umassmed.edu/gsbs_sp/1997 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in GSBS Student 
Publications by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
	 	 STING-IRF3	signaling	in	liver	fibrosis	
	 1	
Endoplasmic reticulum stress-induced hepatocellular death pathways mediate liver injury and fibrosis via 
Stimulator of Interferon Genes 
 
Arvin Iracheta-Vellve, Jan Petrasek, Benedek Gyongyosi, Abhishek Satishchandran,  
Patrick Lowe, Karen Kodys, Donna Catalano, Charles D. Calenda, Evelyn A. Kurt-Jones,  
Katherine A. Fitzgerald, Gyongyi Szabo 
 
From the Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605 
 
Running title: STING-IRF3 signaling in liver fibrosis 
 
To whom correspondence should be addressed: Professor, Gyongyi Szabo M.D., Ph.D., University of 
Massachusetts Medical School, Department of Medicine, LRB208, 364 Plantation Street, Worcester, MA 
01605 Tel: (508) 856-5275; Fax: (508) 856-4770. Email: gyongyi.szabo@umassmed.edu 
 
Key words: carbon tetrachloride; apoptosis; ER stress; fibrosis; STING; IRF3; IRF7 
 
 
ABSTRACT 
Fibrosis, driven by inflammation, marks 
the transition from benign to progressive stages of 
chronic liver diseases. Although inflammation 
promotes fibrogenesis, it is not known whether 
other events, such as hepatocyte death, are 
required for the development of fibrosis. 
Interferon Regulatory Factor 3 (IRF3) regulates 
hepatocyte apoptosis and production of Type-I 
interferons (IFNs). In the liver, IRF3 is activated 
via Toll-like receptor 4 (TLR4) signaling or the 
ER adapter, Stimulator of Interferon Genes 
(STING). We hypothesized that IRF3-mediated 
hepatocyte death is an independent determinant of 
chemically-induced liver fibrogenesis. To test this, 
we performed acute or chronic carbon-
tetrachloride (CCl4) administration to WT, IRF3-, 
TRAM-, TRIF-, and STING-deficient mice. We 
report that acute CCl4 administration to WT mice 
resulted in early ER stress, activation of IRF3 and 
Type-I IFNs, followed by hepatocyte apoptosis 
and liver injury, accompanied by liver fibrosis 
upon repeated administration of CCl4. Deficiency 
of IRF3 or STING prevented hepatocyte death and 
fibrosis both in acute or chronic CCl4. In contrast, 
mice deficient in Type-I IFN receptors or in 
TLR4-signaling adaptors, TRAM or TRIF, 
upstream of IRF3, were not protected from 
hepatocyte death and/or fibrosis suggesting that 
the pro-apoptotic role of IRF3 is independent of 
TLR signaling in fibrosis. Hepatocyte death is 
required for liver fibrosis with causal involvement 
of STING and IRF3. Thus, our results identify that 
IRF3, by its association with STING in the 
presence of ER stress, couples hepatocyte 
apoptosis with liver fibrosis, and indicate that 
innate immune signaling regulates outcomes of 
liver fibrosis via modulation of hepatocyte death 
in the liver.  
 
Fibrosis represents a late-stage of liver 
disease that is common to all chronic liver diseases 
including viral hepatitis, alcoholic and non-
alcoholic fatty liver disease, biliary liver diseases, 
and some genetic liver disease. In spite of their 
specific etiologies, common denominators of 
fibrosis are shared among all these liver diseases, 
including liver inflammation and hepatocyte death. 
Fibrosis results from chronic unresolved liver 
inflammation and may progress from fibrotic 
scarring to cirrhosis that ultimately leads to liver 
failure. Inflammation triggers liver fibrosis via a 
signaling event in which liver resident 
macrophages (Kupffer cells, KC) activate hepatic 
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stellate cells (HSC) to deposit collagen  (1, 2) . 
Liver dysfunction results from the fibrotic tissue 
distorting the liver parenchyma. This process 
involves a dynamic and complex series of 
multicellular events, involving inflammation and 
HSC activation. The hepatocyte is primarily 
responsible for metabolism and detoxification, and 
as such, it is often exposed to damage due to toxic 
metabolites and reactive oxygen species. 
However, the role of hepatocyte death in liver 
fibrosis has been only partially elucidated. Data 
available up to date demonstrate that hepatocyte 
apoptosis activates HSC via paracrine 
mechanisms. Alternatively, HSC can be directly 
activated by apoptotic bodies  (3) . Apoptosis in 
hepatocytes results from displacement or down-
regulation of the Bcl-2 family of anti-apoptotic 
proteins and subsequent activation of pro-
apoptotic BH3-only proteins such as Bax and Bak  
(4) . These events lead to oligomerization of Bax 
and Bak, resulting in permeabilization of the outer 
mitochondrial membrane and execution of the 
intrinsic apoptotic process  (5) . Recently, IRF3, a 
transcription factor that induces interferon-β (IFN-
β), has been shown to play a major role in cell 
death by way of its newly characterized BH3-only 
domain. IRF3 associated with the pro-apoptotic 
adaptor Bax and triggered apoptosis in murine 
embryonic fibroblasts and murine hepatocytes  (6–
8) . However, it is not known whether other key 
signal transduction events in hepatocytes are 
required for the pathogenesis of fibrosis. For this 
reason, we sought to understand the nature of pro-
fibrogenic hepatocyte damage and specifically 
assess the potential role of hepatocyte apoptosis in 
determining the onset of fibrosis. In this study, we 
investigated the role of IRF3 in hepatocyte death 
and liver fibrosis. We used carbon-tetrachloride 
(CCl4), a chemical that, in the short term, induces 
hepatocyte apoptosis  (9)  which is followed by 
secondary necrosis  (10, 11) . When administered 
repetitively, CCl4 induces liver fibrosis  (12) . 
Using two models of CCl4-induced liver injury, we 
investigated the complex multi-cellular events 
associated with fibrosis in a chronic model, as well 
as the tightly-controlled signal transduction events 
associated with early disruption of homeostasis 
and cell death in the acute model. We report that 
hepatocyte-specific endoplasmic reticulum (ER) 
stress and activation of IRF3 occurs and is 
mediated by the ER adaptor, STING. Activated 
IRF3 associates with the pro-apoptotic adaptor 
Bax and induces hepatocyte death. We initially 
hypothesized that IRF3 will utilize established 
pathways of antiviral response, including Type-I 
IFNs, to induce hepatocyte apoptosis. However, 
our results demonstrate that the pro-apoptotic role 
of IRF3 is independent of its function to induce 
Type-I IFNs such as IFN-β. Taken together, our 
data demonstrate that hepatocyte death is 
indispensable in liver fibrosis and that the 
pathogenic role of IRF3 in liver fibrosis is 
mediated via its pro-apoptotic effect in 
hepatocytes. 
 
 
RESULTS  
IRF3 deficiency attenuates chronic CCl4-mediated 
liver injury and fibrosis—Repetitive episodes of 
liver injury, such as those induced by 
administration of CCl4 (a chemical inducer of 
hepatocyte death), result in the development of 
liver fibrosis, which is a hallmark of advanced and 
often irreversible liver disease in humans. We 
previously showed that IRF3-deficient mice were 
protected from alcohol-induced liver disease and 
that IRF3 deficiency in hepatocytes prevented 
fibrogenesis in the liver in alcoholic liver disease 
(8). We evaluated this hypothesis using a mouse 
model of liver injury and fibrosis using CCl4 or 
vehicle, in a six-week regimen of bi-weekly 
intraperitoneal injections. Deficiency of IRF3 
significantly attenuated liver damage, as  
 
 
 
demonstrated by significantly lower levels of 
serum ALT and substantially improved 
histological findings compared to CCl4-treated 
wild-type controls (Fig.1A,B)., IRF3-deficient 
mice had decreased TUNEL positive staining in 
the liver compared to WT mice, suggestive of 
decreased apoptosis (Fig.1C). Interestingly, 
TUNEL positive staining was predominantly 
present in hepatocytes. IRF3-deficient mice 
showed significant protection from liver fibrosis, 
indicated by reduced alpha-smooth muscle actin 
(α-SMA) immunohistochemistry and Sirius-red 
staining compared to WT mice (Fig.1D,E). The 
protection from liver fibrosis in IRF3-deficient 
mice was accompanied  by significantly lower 
expression of Acta2 and Col1a2 (Fig.1F), 
 at U
niversity of M
assachusetts M
edical Center/The Lam
ar Soutter Library on D
ecem
ber 19, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
	 	 STING-IRF3	signaling	in	liver	fibrosis	
	 3	
encoding α-SMA and Type-I collagen, and by 
decreased expression of Ifnb and Isg15, two 
commonly used markers of IRF3-mediated 
transcriptional response (Fig.1G). 
Acute CCl4 induces ER stress and 
phosphorylation of IRF3 in hepatocytes—
Disruption of intracellular homeostasis can lead to 
an accumulation of misfolded proteins associated 
with the unfolded protein response  (UPR) in the 
ER, also known as ER stress. Excessive ER stress 
is associated with pro-apoptotic signaling and can 
be pathogenic  (13, 14) . To test if CCl4-induced 
acute hepatocyte injury induces an early ER stress 
response, we analyzed livers of mice at various 
time points after a single administration of CCl4. 
We found an early upregulation of Xbp1 mRNA 
splicing (sXbp1), a marker of early ER stress  (15, 
16)  at one and two hours after administration of 
CCl4  (Fig.2A). Analysis of cell populations from 
murine livers showed that CCl4 selectively 
upregulated Xbp1 mRNA splicing in hepatocytes 
but not in liver mononuclear cells (LMNCs) 
(Fig.2B). 
Previous reports have shown that ER 
stress results in IRF3 activation in mouse 
embryonic fibroblast, and that Xbp1 splicing 
enhances the IFN-β response in immune cells  (17, 
18) . In our study, acute administration of CCl4 led 
to an early activation of IRF3, a pro-apoptotic 
BH3-only protein, as seen by the phosphorylation 
in whole cell liver lysates (Fig.2C), at the same 
time as splicing of Xbp1 mRNA (Fig.2A). The 
phosphorylation of IRF3 had a functional effect, as 
liver Ifnb1 mRNA and serum IFN-β, 
transcriptional targets of IRF3, showed an early 
upregulation (Fig.2D). To test if direct induction 
of ER stress can lead to IRF3 phosphorylation, we 
treated primary hepatocytes with thapsigargin in 
vitro and found an early increase in 
phosphorylated IRF3 (Fig.2E). Furthermore, 
inhibition of Tank-binding kinase 1 (TBK1), a 
kinase responsible for IRF3 phosphorylation, with 
BX795 showed a dose-dependent reduction in 
IRF3 phosphorylation in thapsigargin-treated 
hepatocytes (Fig.2E). Building upon previous 
findings, our data indicate that acute 
administration of CCl4 results in hepatocyte-
specific ER stress and phosphorylation of IRF3 in 
vivo, and that in vitro inhibition of a kinase 
upstream of IRF3 inhibited phosphorylation of 
IRF3 induced by ER stress. Our data support the 
hypothesis that CCl4 activates IRF3 in hepatocytes 
via ER stress. 
Acute CCl4-induced liver injury is 
ameliorated by the deficiency of IRF3 independent 
of TRIF or TRAM, or Type-I IFN signaling—Next, 
we asked if IRF3 plays a role in liver injury after 
acute CCl4 administration.  We found that IRF3-
KO mice were partially protected from liver injury 
after acute CCl4 administration, as indicated by the 
significant attenuation in serum ALT compared to 
WT controls (Fig.3A) and Caspase-3 cleavage in 
the liver (Fig.3B). To test if the pathogenic 
phenotype of IRF3 involvement was mediated by 
its function as a transcription factor, we tested 
mice deficient in Type-I IFN receptor (IFNAR1) 
that lack Type-I IFN signaling and found that 
IFNAR1-KO mice had no protection from CCl4-
mediated liver injury, phosphorylation of IRF3 or 
apoptotic signaling in the liver compared to WT 
mice (Fig.3C,D). This data suggested that the 
pathogenic role of IRF3 may be independent of its 
transcriptional role.  
CCl4-induced liver fibrosis activates 
hepatic stellate cells via TLR4  (19, 20),  enhanced 
by signal transduction emanating from the TLR4 
complex induced by gut bacterial products and 
LPS  (1) . To investigate if activation of IRF3 in 
acute CCl4-liver injury was mediated by the 
intracellular MyD88-independent TLR4 adaptors 
TIR-domain-containing adapter-inducing 
interferon-β (TRIF) and TRIF-related adaptor 
molecule (TRAM), or the kinase TBK1, we first 
inhibited activity of their downstream kinase, 
TBK1, by the chemical inhibitor BX795 in vivo. 
Pre-treatment of mice with BX795 significantly 
attenuated the extent of liver injury and apoptotic 
signaling in the liver after administration of CCl4 
(Fig.3E,F). The decrease in phosphorylated IRF3 
(Fig.3F) with BX795 pre-treatment further 
suggests that IRF3 requires activation and 
phosphorylation of TBK1 in order to exert a 
pathogenic effect in CCl4-induced liver injury. In 
contrast, TRAM- and TRIF-KO mice were each 
equally as susceptible to acute CCl4 damage and 
apoptosis in the liver as WT mice (Fig.3G,H). 
Importantly, TRAM- and TRIF-KO mice had 
similar levels of phosphorylated IRF3 compared to 
WT mice (Fig.3H), suggesting that IRF3 
activation by acute CCl4 occurs independent of the 
TLR4 receptor complex and its adaptors. Together 
this data suggested that TBK1-mediated activation 
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of IRF3 is pathogenic, leading to increased liver 
injury. Furthermore, Type-I IFNs do not have a 
significant role in acute liver injury after CCl4 
administration in spite of being activated by IRF3. 
Lastly, activation of IRF3 by acute CCl4 is 
independent of the canonical MyD88-independent 
TLR4 adaptor-mediated receptor signaling. 
Therefore, we hypothesized that activation of 
IRF3 in the liver by acute CCl4 likely involves 
different signaling pathways. 
CCl4 induces early association of IRF3 
with STING in the ER and association of IRF3 
with Bax in the mitochondria in the liver—Given 
the robust protection from acute or chronic CCl4-
induced liver injury in mice deficient in IRF3, we 
next investigated subcellular localization and 
mechanisms of early IRF3 activation. First, we 
evaluated the kinetics of IRF3 activation in WT 
mice upon acute CCl4-mediated injury and found 
an early phosphorylation of IRF3 at two and four 
hours in whole cell liver lysates (Fig.4A). Next, 
we analyzed the intracellular distribution of IRF3. 
Analysis of subcellular liver fractions revealed that 
administration of CCl4 resulted in localization of 
phosphorylation of IRF3 not only in the 
cytoplasmic (Fig.4B) and nuclear extracts 
(Fig.4C), but also in the ER (Fig.4D) and 
mitochondrial fractions (Fig.4E). The finding of 
phosphorylated IRF3 in cytoplasmic and nuclear 
extracts (Fig.4A,B) was consistent with the 
transcriptional role of IRF3 in induction of Ifnb. 
However, the finding of phosphorylated IRF3 in 
the ER (Fig.4D) and mitochondria (Fig.4E) was 
unexpected and prompted us to search for ER- and 
mitochondria-specific binding partners of IRF3. 
It has been reported that during viral 
infections, IRF3 associates with ER via binding to 
Stimulator of IFN Gene (STING, alias Tmem173 
or MPYS), an adaptor protein residing in the ER 
membrane. We found that a single administration 
of CCl4 in vivo resulted in a significant increase in 
STING in whole cell liver lysates (Fig.4F) and in 
ER extracts (Fig.4H) after a pull-down with IRF3 
antibody, suggesting an association between IRF3 
and STING in the liver of mice exposed to CCl4.   
Based on the recent report that IRF3 plays 
a key role in viral-mediated apoptosis mediated by 
Bax  (6) , and on our previous report data that 
IRF3 is required for hepatocyte apoptosis triggered 
by FasL  (8) , we hypothesized that IRF3 would 
associate with pro-apoptotic proteins involved in 
the intrinsic, mitochondrial pathway of 
hepatocytes apoptosis. We found an increased 
association between IRF3 and Bax at two hours 
after administration of CCl4 (Fig.4I), followed by 
Casp-8 activation and apoptosis (Fig.4J,K). The 
timing of this association correlates with the 
increased presence of phosphorylated IRF3 in the 
mitochondrial fraction, suggesting that only active 
and phosphorylated IRF3 has a pro-apoptotic role 
when found in the mitochondria. Moreover, the 
presence of phosphorylated IRF3 in the 
mitochondria and its association with BAX 
coincided with activation and cleavage of the 
initiator Caspase-8 and the executioner Caspase-3 
(Fig.4J). Our data suggest that ER stress and 
phosphorylation of IRF3 (Fig.2A,C), which 
occurred within one hour, was followed by pro-
apoptotic signaling and hepatocyte damage 
(Fig.4I,J,K), which were established within two 
hours. Taken together, our data indicated that 
following acute administration of CCl4, IRF3 
interacts with the ER-associated protein, STING, 
and with the pro-apoptotic molecule, Bax. 
Importantly, the association of IRF3 with STING 
or phospho-TBK1 in the ER occurred within the 
first two hours after CCl4 administration 
(Fig.4F,H,G), concurrent with phosphorylation of 
IRF3 and upregulation of Ifnb in the liver 
(Fig.2C,D); all of these events occurred prior to 
the development of significant liver injury (Fig.3).  
Deficiency in STING, but not in Type-I 
IFN signaling, attenuates liver fibrosis—Acute 
CCl4-induced liver injury resulted in ER stress and 
IRF3 activation, as well as early localization of 
IRF3 in the ER in association with STING, an ER-
adaptor protein. Furthermore, IRF3 demonstrated 
a pathogenic role, independent of the TLR4-
adaptor complex, in models of acute or chronic 
CCl4-induced liver injuries, we then hypothesized 
that activation of IRF3 was through STING after 
chronic CCl4 administration in mice. In support of 
this hypothesis, we observed that Tmem173Gt 
mice, which lack the STING protein  (21)  had 
significantly attenuated liver injury induced by 
repetitive injections of CCl4 (Fig.5A,B) to a 
similar extent to that observed in IRF3-deficient 
mice (Fig.1A). Further, STING-deficient mice 
(Tmem173Gt) showed protection from liver 
fibrosis (Fig.5C) as well as a decrease in 
deposition α-SMA and Type1-Collagen protein in 
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the liver (Fig. 5D,E) and expression of pro-
fibrogenic markers (Fig.5F).  
IRF3 is the transcription factor responsible 
for Type-I IFN production, a pro-inflammatory 
cytokine important in creating an antiviral state. In 
addition to IRF3, IRF7 is another major regulator 
of Type-I IFN production  (22) . Administration of 
CCl4 resulted in significantly upregulated Ifnb1 
and the IFN inducible gene Isg15 in the liver in 
WT mice, while IRF3-deficient mice lacked 
induction of Type-I IFN genes (Fig.1F). However, 
IRF7 or Type I IFNs did not mediate the 
pathogenic effect of IRF3 in the liver as 
demonstrated by lack of protection from liver 
injury (Fig.5H,I) and fibrosis (Fig.5J,K) in IRF7- 
or IFNAR1-KO mice, respectively. The lack of 
Type-I IFN induction or signaling in INFAR1-KO 
mice resulted in aggravated liver fibrosis, as 
demonstrated by increased Sirius-red area (Fig.5J) 
and augmented expression of Acta2 and Col1a2 
(Fig.5K) compared to WT mice, which is 
consistent with the previously reported anti-
fibrotic role of Type-I IFNs  (23, 24) . Taken 
together, this data implied that IRF3, but not IRF7 
or Type-I IFN signaling, play a pathogenic role in 
chronic liver injury and fibrosis induced by 
chronic CCl4 administration. In addition, the data 
demonstrate the pathogenic role of STING, a 
binding partner of IRF3 (Fig.4 and (25) ), as a 
determinant in the development of liver injury and 
fibrosis in this model.  
STING mediates pro-apoptotic activation 
of IRF3 in a chronic CCl4-induced model of 
fibrosis—To further characterize the role of 
STING in mediating the CCl4-induced liver injury 
in the chronic CCl4 model, we evaluated 
phosphorylation of TBK1 and IRF3. After six 
weeks of exposure to CCl4, STING-deficient mice 
had decreased phosphorylation of TBK1 (Fig.6A) 
as well as decreased phosphorylation of IRF3 
(Fig.6B) compared to WT mice. Previous reports 
have studied the pro-apoptotic association of IRF3 
with Bax. To test if STING-mediated activation of 
IRF3 results in pro-apoptotic signaling, we tested 
Caspase activation in STING-deficient mice using 
the chronic CCl4-mediated liver injury model. We 
found that STING-deficient mice (Tmem173Gt) 
given a six-week regimen of CCl4 exhibited a 
significant reduction in the cleavage and activation 
of the apoptosis initiator Caspase-8 (Fig.6C) and 
the apoptosis executioner Caspase-3 (Fig.6D) 
compared to WT mice.  
This data was consistent with the 
association between IRF3, STING and Bax that 
we found in the liver following a single exposure 
to CCl4 (Fig.4H,I) and indicated the possibility 
that ER stress may be a source of IRF3 activation 
in this model. In addition, this data also supported 
the possibility that in the chronic model of CCl4-
induced liver injury and fibrosis, IRF3 represents 
an activator of pro-apoptotic signaling in the liver. 
Early pro-apoptotic activation of IRF3 by 
CCl4 is hepatocyte-specific and mediated by 
STING—To further explore the mechanism of cell 
death and liver injury and to test whether induction 
of cell death in the acute CCl4 liver injury model 
was mediated by STING, we evaluated activation 
of Caspase-8 and Caspase-3 in mouse livers. We 
found that Caspase-8 and -3 were both activated at 
8 and 12 hours after CCl4 injection in WT mice 
(Fig.7A,B), while the STING-deficient mice 
(Tmem173Gt) had complete absence of cleaved 
caspases (Fig.7C,D).  
To better understand the underlying 
mechanism behind the protection observed in mice 
deficient in either IRF3 or STING in a chronic 
CCl4 injury, we tested the dynamics of hepatocyte 
damage by comparing WT mice with Tmem173Gt 
mice during an acute CCl4 liver injury. We found 
protection from liver injury in STING-deficient 
mice (Tmem173Gt) after CCl4 administration as 
seen by serum ALT and H&E histology 
(Fig.7E,F). WT mice exhibited extensive necrosis 
at 12 hours, peaking at 24 hours, as seen by 
irregular histological morphology, while the 
STING-deficient mice did not (Fig.7F). 
Surprisingly, we found that one dose of CCl4 was 
sufficient to elicit a pro-fibrogenic response in WT 
mice as early as 24 hours after injection 
(Fig.7G,H). In comparison to WT mice, the 
STING-deficient mice (Tmem173Gt) were 
protected from this early pro-fibrogenic response 
in the liver. 
Our data established that CCl4-mediated 
ER stress occurred primarily in hepatocytes and 
that phospho-IRF3 after ER stress occurs in 
primary hepatocytes (Fig.2B,C). To assess which 
liver cell type is responsible for IRF3 
phosphorylation and caspase activation after CCl4 
administration in vivo, we isolated liver 
mononuclear cells (LMNCs), hepatic stellate cells 
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(HSCs) and primary hepatocytes from mouse 
livers 9 hours post CCl4 injection. We found that 
phosphorylation of IRF3 occurred predominantly 
in hepatocytes, and not in LMNCs or HSCs 
(Fig.7I). In assessing cell type-specific 
contribution to apoptotic signaling, we found 
increased Casp-8 cleavage in hepatocytes but not 
in HSCs or LMNCs. Similarly, there was an 
increase in Caspase-3 cleavage predominantly in 
hepatocytes, albeit some cleaved Caspase-3 was 
detected in HSCs (Fig.7I). The phosphorylation of 
IRF3 and Caspase-8 cleavage found exclusively in 
the hepatocyte population was consistent with our 
previous findings of TUNEL positive staining in 
hepatocytes (Fig.1C) and in IRF3 association with 
Caspase-8 and BAX in total liver lysates (Fig.4I).  
Taken together, this data demonstrated 
that activation of IRF3 in acute or chronic liver 
damage is triggered in hepatocytes via the adaptor 
STING. Deficiency in either STING or IRF3 
resulted in significant decreased hepatocyte death 
and fibrosis. 
 
DISCUSSION Previous studies described the role 
of STING activation in viral infections in immune 
cells  (26–30) . In hepatocytes, we demonstrated 
earlier that STING and IRF3 mediate the 
pathogenesis in alcoholic liver disease, a role 
independent of microbial components  (8) . In the 
present study, our data demonstrate a hepatocyte-
specific role of STING and IRF3 in mediating 
hepatic apoptosis as an early event in the 
development of liver fibrosis.   
Hepatocytes are responsible for 
metabolism and for detoxifying portal blood, 
which can be rich in bacterial products. For this 
reason, innate immunity plays an important role in 
the liver; even though this organ is rich in immune 
cells, parenchymal cells have an abundance of 
receptors and are capable of initiating immune 
signaling  (31–34) . In our study, TBK1-mediated 
ER stress was detected early after CCl4-
administration only in hepatocytes and not in 
LMNCs. Similarly, phosphorylated IRF3 was 
detected in hepatocytes exposed to CCl4 in vivo 
but not in LMNCs or HSCs. Furthermore, in 
support of our hypothesis of the pro-apoptotic role 
of IRF3, CCl4-mediated Caspase-8 cleavage was 
detected only in hepatocytes and was absent from 
LMNCs and HSCs. Lastly, compared to 
hepatocytes exposed to CCl4, Caspase-3 cleavage 
was reduced in HSCs and absent in LMNCs. The 
decreased level of Caspase-3 cleavage in HSCs 
compared to hepatocytes is likely due to the 
absence of concurrent phosphorylated IRF3 and 
Caspase-8 cleavage, suggesting of an alternate 
mechanism of toxicity and cell death signaling 
independent of IRF3 in HSCs. It is possible that 
the mechanisms that tightly regulate apoptotic 
signaling may also be responsible for hepatic 
stellate cell activation, leading to fibrogenesis. 
Regulated IRE1-dependent decay of 
mRNA (RIDD), a key component of the unfolded 
protein response, results in degradation of viral 
mRNA transcripts and spliced Xbp1  (13, 35) . 
However, there are multiple lines of evidence 
suggesting that IRF3 activation can result from 
other forms of noninfectious cell damage that 
involve Xbp1 splicing  (17, 18, 36) .  
Here we show that STING activation may 
provide the link between induction of ER stress 
and IRF3. Moreover, the rapid nature of the 
phosphorylation of IFR3 and Xbp1 splicing in our 
experiments due to an acute CCl4-induced liver 
injury underscores the importance of STING and 
its location in the ER.  
Viral infections as well as noninfectious 
injuries are associated with induction of cell death 
signals, emphasizing the importance of the BH3-
domain within IRF3 as responsible for its pro-
apoptotic properties in the mitochondria. It is also 
possible that CCl4-induced cell death signaling 
from STING activation of IRF3 and BAX may 
trigger ER membrane permeability  (37)  in 
addition to the effects on the mitochondrial 
membrane integrity.  
A previous study by Knockaert et al. (38)  
of CCl4 in mouse livers interestingly found no 
apoptosis or pro-apoptotic caspase activity at three 
or 24 hours, the only two time-points they tested. 
It is important to highlight that our data showed 
Caspase-8 and -3 cleavage peaking between eight 
and twelve hours in WT mice, while apoptotic 
signaling had resolved by 24 hours (Fig.7A,B). 
Importantly, the STING-deficient mice had no 
detectable Caspase-8 or -3 cleavage (Fig.7C,D), 
indicating protection from apoptosis and 
secondary cell death.  
Moreover, the Knockaert et al. study 
similarly found CCl4-mediated necrosis at 24 
hours (Fig.4K,7F), further supporting our 
hypothesis that early, and extensive pro-apoptotic 
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signaling leads to necrosis, or secondary necrosis, 
which have overlapping components  (39) . In 
support of the study by Roychowdhury et al.  (40),  
our data indicate that an absence of early apoptosis 
is also associated with an absence in early 
fibrogenesis and detectable necrosis at the level of 
liver histology in STING-deficient mice.  
Pro-apoptotic signaling may play a 
beneficial role in the resolution of inflammation 
after liver injury, specifically when it is targeted to 
infiltrating immune cells such as neutrophils  (41).  
Uncontrolled parenchymal apoptosis, however, 
although typically controlled and tightly regulated, 
may be the tipping point responsible for 
subsequent necrosis.  
As summarized in Fig.7J, our data suggest 
that overwhelming levels of IRF3-mediated 
apoptosis may eventually lead to a form of 
secondary necrosis. Taken together, our data 
provides strong evidence that inhibition of 
parenchymal apoptotic signaling is sufficient to 
reduce necrosis and amplified liver damage.  
In conclusion, our study builds on the 
previous paradigm of fibrogenesis. The CCl4-
induced liver damage, ER stress and death of 
hepatocytes is mediated by the engagement of the 
ER adaptor protein, STING, with phosphorylated 
IRF3, resulting in activation of the mitochondrial 
pathway of hepatocyte death. As such, fibrosis is 
more than a pathology strictly driven by 
inflammation. Rather, hepatocyte death appears to 
be a separate key component in the process of 
liver fibrosis.  
EXPERIMENTAL PROCEDURES  
Animal studies—6- to 8-week-old female C57Bl/6 
WT (Jackson Laboratory, Bar Harbor, ME), IRF3-
deficient (IRF3-KO) or type I IFN α/β receptor 1-
(IFNAR1)-KO mice (provided by J. Sprent, 
Scripps Research Institute, La Jolla, CA) and 
IRF7-KO mice (provided by T. Taniguchi, Tokyo, 
Japan), all on C57Bl/6 background, were used. 
The STING-deficient (Tmem173Gt) mice 
(provided by R. Vance, University of California, 
Berkeley, CA) and the TRAM- and TRIF-KO 
mice (provided by S. Akira, Osaka University, 
Japan) were on the B6.129sf2 background; we 
used B6.129sf2 WT mice (Jackson Laboratory) as 
controls for these strains. Some mice received a 
single intraperitoneal (i.p.) injection of carbon 
tetrachloride (CCl4), 0.6 µL/gram body weight, 
diluted 1:3 in corn oil (Sigma, St. Louis, MO). 
Other mice received a six-week regiment of CCl4 
injections, given twice per week. All animals 
received proper care in agreement with animal 
protocols approved by the Institutional Animal 
Use and Care Committee of the University of 
Massachusetts Medical School.  
In vitro experiments—Primary hepatocytes and 
liver mononuclear cells were isolated as described 
previously (42). Primary hepatocytes were 
cultured in Waymouth’s medium supplemented 
with 10% fetal bovine serum and 1% insulin, 
transferrin, selenium solution. Primary hepatocytes 
were seeded in 6-well collagen-coated plates 
(Biocoat, Becton Dickinson, Bedford, MA). 
Before starting stimulation experiments, 
hepatocytes were rested for 4 hours. Subsequently 
culture media was replaced, and stimulation was 
performed as indicated in the figure legends. The 
BX795 (10µM or 100µM) and thapsigargin (1µM) 
were purchased from Sigma (St. Louis, MO). 
RNA Analysis—RNA analysis and PCR primers 
are described in Table 1. sXbp1 PCR was 
performed and products were separated on 3% 
agarose gel as described previously  (8) . 
Protein quantification—Liver whole-cell lysates 
and nuclear preparations were extracted as 
described previously  (8) . Mitochondrial and total 
ER fractions were prepared using specific 
extraction kits from Imgenex (San Diego, CA) as 
per manufacturer’s protocol. Immunoblotting was 
performed as described in (43). Antibodies 
specific for phospho-IRF3, phospho-TBK1, 
STING, Casp-8, Casp-3, cleaved Casp-8, cleaved 
Casp-3 and Bax were from Cell Signaling 
(Danvers, MA). Antibodies against the total IRF3, 
GRP78 and KDEL, and control IgG were from 
Santa Cruz (Santa Cruz Biotechnology, Santa 
Cruz, CA). Beta-actin, beta-tubulin, porin and 
TATA-binding protein (TBP) antibodies were 
from Abcam (Cambridge, MA). The TrueBlot 
system from eBioscience (San Diego, CA) was 
used for immunoprecipitation assays and 
performed as per manufacturer’s instructions. 
Statistical Analysis—Statistical significance was 
determined using two-sided t-test; Two-way 
ANOVA was used in Figures 3A-D and Figure 7E 
to determine the global effect of BX795 on serum 
ALT. Numbers in the graphs indicate global P 
values. Data are shown as scatter plots of 
individual data plots ± S.D. to represent error and 
were considered statistically significant at P < 
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0.05. Symbols *P < 0.05 vs. baseline; **<0.001 
vs. baseline; #P < 0.05 vs. WT CCl4 condition; 
##P < 0.001 vs. WT CCl4 condition. We used 
SPSS 19.0 (IBM SPSS, Chicago, IL) and 
GraphPad Prism 6.0 (San Diego, CA) for 
calculations. 
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 FOOTNOTES 
The abbreviations used are: Interferon Regulatory Factor 3 (IRF3); interferons (IFNs); Stimulator of 
Interferon Genes (STING); carbon tetrachloride (CCl4); hepatic stellate cells (HSC); endoplasmic 
reticulum (ER); alpha-smooth muscle actin (α-SMA); unfolded protein response (UPR); Type-I IFN 
receptor (IFNAR1); TIR-domain-containing adapter-inducing interferon-β (TRIF); TRIF-related adaptor 
molecule (TRAM); Tank-binding Kinase 1 (TBK1); Regulated IRE1-dependent decay of mRNA (RIDD). 
 
FIGURE LEGENDS 
FIGURE 1. IRF3 deficiency attenuates chronic CCl4-mediated liver injury and fibrosis. WT or IRF3-KO 
mice injected with oil or CCl4 for six weeks and sacrificed 48 hours after final injection. Liver injury was 
assessed by serum ALT (A) and H&E staining (B). Liver apoptosis was assessed via TUNEL staining 
(black arrows) on paraffin-embedded liver sections (C). Liver fibrosis was evaluated by Sirius-red 
staining (D) and alpha-smooth muscle actin immunohistochemistry (E), and quantified using ImageJ. 
mRNA expression in liver for Acta2 and Col1a2 (F) as well as Ifnb1 and Isg15 (G) were measured by 
RT-PCR to assess liver fibrosis and IRF3 activation, respectively. N= 6-7 mice (CCl4-treated, per 
genotype); 3-4 mice (oil-treated, per genotype). 
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FIGURE 2. Acute CCl4 induces ER stress and TBK1-mediated phosphorylation of IRF3 in hepatocytes. 
WT mice received a single injection of corn oil or CCl4. At indicated time points, mice were sacrificed, 
and splicing of Xbp1 mRNA (sXBP1) in the liver, indicating ER stress, was evaluated by PCR, and 
products were separated on 3% agarose gel (A). Two hours after CCl4 administration, hepatocytes or 
LMNCs from WT mice were isolated and analyzed for sXBP1 by PCR (B). At indicated time points, 
phosphorylation of IRF3 was assessed by immunoblotting in liver (C) while Ifnb1 mRNA expression in 
liver and as serum IFN-β were measured by RT-PCR and ELISA, respectively (D). N= 4 mice per time 
point. Primary hepatocytes isolated from WT mice were treated with 1µM thapsigargin, and were 
pretreated with DMSO or BX795 (10µM or 100µM), and analyzed for phospho-IRF3 (E).  
 
FIGURE 3. Acute CCl4-induced liver injury is ameliorated by the deficiency of IRF3 or inhibition of 
TBK1,  independent of TRIM or TRAM , Type-I IFN signaling. WT or IRF3-KO mice received a single 
injection of CCl4. Serum ALT levels were assessed (A) and apoptosis was assessed by measuring 
Caspase-3 cleavage in the liver by immunoblot (B). WT or IFNAR1-KO mice received a single injection 
of CCl4. Serum ALT levels were assessed (C) and IRF3 activation and apoptosis were assessed by probing 
for phosphor-IRF3 and Caspase-3 cleavage in the liver by immunoblot (D).  WT were pretreated with 
DMSO or BX795, a TBK1-inhibitor, two hours before receiving a single injection of corn oil (vehicle) or 
CCl4. Serum ALT levels were assessed (E) and IRF3 activation and apoptosis were assessed by probing 
for phosphor-IRF3 and Caspase-3 cleavage in the liver by immunoblot (F). WT, TRIF- or TRAM-KO 
mice received a single injection of CCl4 . Serum ALT levels were assessed (G) and IRF3 activation and 
apoptosis were assessed by probing for phosphor-IRF3 and Caspase-3 cleavage in the liver by 
immunoblot (H). Mice were bled serially at indicated time points. N= 8-9 mice (CCl4-treated, per 
genotype); 3-4 mice (oil-treated, per genotype) (A,C,G). N= 3-5 mice (CCl4-treated, pre-treated with 
BX795); 3 mice (oil-treated, pre-treated with DMSO) (E). 
 
FIGURE 4. Acute CCl4 induces early association of IRF3 with STING in the ER and association of IRF3 
with Bax in the mitochondria in the liver. WT mice received a single injection of CCl4. At indicated time 
points, mice were sacrificed, and phosphorylation of IRF3 was assessed by immunoblotting in liver 
whole-cell lysate (A) or cytoplasmic (B), nuclear (C), ER (D), and mitochondrial (E) extracts. Using 
immunoprecipitation with anti-total IRF3 antibody for protein pull-down, we evaluated association 
between total IRF3 and phosphorylated TBK1 or STING in the whole-cell (F), mitochondrial (G), and ER 
(H) extracts. Similarly, we evaluated association between total IRF3 and cleaved Caspase-8 p43 fragment 
or BAX in liver whole-cell lysate (I), with representative IgG control shown (two hours after injection). 
At indicated time points, cleavage of Caspase-8 and Caspase-3 was assessed by immunoblotting in liver 
(J). Liver injury and apoptosis was assessed by H&E liver histology and TUNEL staining on paraffin-
embedded liver sections (K). ). N= 4 mice per time point. 
FIGURE 5. Deficiency in STING, but not in Type-I IFN signaling, attenuates liver fibrosis. WT or 
STING-deficient mice (Tmem173Gt) were injected with oil or CCl4 for six weeks and sacrificed 48 hours 
after final injection. Liver injury was assessed by serum ALT (A) and H&E staining (B). Liver fibrosis 
was evaluated by measuring Sirius-red staining  and the percent-positive area stained was quantified using 
ImageJ (C). Liver fibrosis was also evaluated by immunoblot for alpha-smooth muscle actin (D) or Type-
1 collagen (E). mRNA expression in liver for Acta2 and Col1a2 (F) as well as Ifnb1 and Isg15 (G) were 
measured by PCR to assess liver fibrosis and IRF3 activation, respectively. WT, IRF7- or IFNAR1-KO 
mice injected with oil or CCl4 for six weeks and sacrificed sacrificed 48 hours after final injection. Liver 
injury was assessed by serum ALT (H) and H&E staining (I). Liver fibrosis was evaluated by Sirius-red 
staining and quantified using ImageJ (J). mRNA expression in liver for Acta2 and Col1a2 (K) as well as 
Ifnb1 and Isg15 (L) were measured by RT-PCR. N= 8-9 mice (CCl4-treated, per genotype); 3-4 mice (oil-
treated, per genotype). 
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FIGURE 6. STING mediates pro-apoptotic activation of IRF3 in a chronic CCl4-induced model of 
fibrosis. WT or STING-deficient mice (Tmem173Gt) were injected with oil or CCl4 for six weeks and 
sacrificed. Whole cell liver lysates were probed for phosphorylated TBK1 (A), phosphorylated IRF3 (B), 
cleaved Caspase-8 (C), and cleaved Caspase-3 (D) by immunoblot. N= 8-9 mice (CCl4-treated, per 
genotype); 3-4 mice (oil-treated, per genotype). 
 
FIGURE 7. Early pro-apoptotic activation of IRF3 by CCl4 is hepatocyte-specific and mediated by 
STING. WT or STING-deficient mice (Tmem173Gt) received a single injection of CCl4 or oil (baseline) 
and sacrificed at indicated time-points. Whole cell liver lysates were probed for cleaved Caspase-8 (A,B), 
and cleaved Caspase-3 (C,D) by immunoblot. Liver injury was assessed by serum ALT (E) and H&E 
staining at indicated time points (F). Deposition of alpha-smooth muscle actin (α-SMA) 24hrs after 
injection was evaluated by immunoblots from whole cell liver lysate (G), while mRNA expression in 
liver for Acta2 and Col1a2 (H) was assessed by PCR. N= 5-8 mice per time point, per genotype (A-H). 
WT mice received a single injection of CCl4 or oil (baseline) and sacrificed nine hours later. Liver 
mononuclear cells (LMNC), hepatic stellate cells (HSC) or hepatocytes were isolated from livers and 
probed for phosphorylated IRF3, total IRF3, cleaved Caspase-8 and cleaved Caspase-3 by immunoblot 
(I). N=3 per condition (LMNC and HSC were pooled from 3 mice); N=1 (hepatocytes isolated from 
single mouse per condition); experiment was repeated three times (I). Schematic of pro-apoptotic STING 
and IRF3 activation from CCl4 administration in mice (J).  In CCl4-treated hepatocytes, ER stress results 
in phosphorylation of TBK1 via STING, followed by phosphorylation of IRF3. IRF3 associates with 
BAX in the mitochondria through its BH3-only domain, leading to pro-apoptotic Caspase-3 activation 
and hepatocyte apoptosis. After chronic CCl4 administration, hepatocyte apoptosis is associated with 
secondary necrosis, which results in liver fibrosis. 
 
Table 1 
qPCR primers 
Target gene   Forward primer(5’→ 3’)   Reverse primer(5’→ 3’) 
18S    gtaacccgttgaaccccatt   ccatccaatcggtagtagcg 
Tnfa    caccaccatcaaggactcaa    aggcaacctgaccactctcc 
Ifnb    agctccaagaaaggacgaacat   gccctgtaggtgagggttgatct 
Isg15    caggacggtcttaccctttcc   aggctcgctgcagttctgtac 
Xbp1    acacgcttgggaatggacac    ccatgggaagatgttctggg 
Acta2    acacgcttgggaatggacac    ttcctgaccactagaggggg  
Col1a2   ggagggaacggtccacgat    gagtccgcgtatccacaa  
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